Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases
Chimeric antigen receptor T (CAR-T) cells are T cells engineered to express specific synthetic antigen receptors that can recognize antigens expressed by tumor cells, which after the binding of these antigens to the receptors are eliminated, and have been adopted to treat several kinds of malignanci...
Saved in:
Main Authors: | Yuehong Chen, Jianhong Sun, Huan Liu, Geng Yin, Qibing Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2019/5727516 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR T cells for treating autoimmune diseases
by: Dimitrios Mougiakakos, et al.
Published: (2023-11-01) -
Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies
by: Shangjun Sun, et al.
Published: (2018-01-01) -
CAR T-cells to drive away autoimmunity in lupus
by: Sakir Ahmed
Published: (2019-01-01) -
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
by: Qiaolin Huang, et al.
Published: (2025-02-01) -
T-regulatory cells for the treatment of autoimmune diseases
by: Marina S. Fisher, et al.
Published: (2025-02-01)